New Pradaxa Bleeding Data Is Nothing Short of Terrifying

This is Michael Brady Lynch, lead trial attorney for The Michael Brady Lynch Firm.
 
The latest data is out on Pradaxa bleeding events and the numbers are nothing short of downright terrifying.
 
Pradaxa manufacturer Boehringer Ingelheim just put online on “pradaxa.de” some new data on fatal/major bleeds as reported to the company up to end of  2013.
 
It is shocking to see that despite decreasing Pradaxa prescriptions still, about 60 patients die every month from a Pradaxa bleed.
 
Green figures are calculated and can be compared with data released by the Institute for Safe Medication Practices:

31. March 2013 30. June 2013 30. Sept 2013 31. Dec 2013
Fatal bleeds 1.163 1.448 1.637 1.646
Majors bleeds (include fatal) 7.601 9.138 9.939 10.798
Major bleeds (non fatal) 6.438 7.690 8.302 9.152
fatal bleeds as % of major bleeds  18 19 20 18
 
The only logical conclusion is that the high case fatality of a major bleed with Pradaxa support the hypothesis that the irreversible nature of Pradaxa is responsible for the catastrophic outcome following a bleeding event.
If you or a loved one was prescribed Pradaxa and suffered a bleeding event, contact The Michael Brady Lynch Firm for a no-cost, no-obligation review of your case.

About the Firm: The Michael Brady Lynch Firm is a trial firm with a focus on pharmaceutical mass tort cases involving SSRI and Anti-Seizure Medication Birth Defects including Lexapro, Zoloft, Effexor, Prozac, Celexa, Paxil, Depakote and Topamax, Mirena IUD, Pradaxa internal bleeding, Actos Bladder Cancer, Lipitor diabetes cases, and medical device cases including DePuy Hip and Trans-Vaginal Mesh cases. Contact us today if you or someone you know has experienced side effects involving these products.

Leave a Reply

Your email address will not be published. Required fields are marked *

Contact Us Today

Contact our lawyers directly through the email form below.
  • * Denotes a required field
  • This field is for validation purposes and should be left unchanged.